Shuangxinfang Prevents S100A9-Induced Macrophage/Microglial Inflammation to Improve Cardiac Function and Depression-Like Behavior in Rats After Acute Myocardial Infarction
Background: Depression is a common complication of cardiovascular disease, which deteriorates cardiac function. Shuangxinfang (psycho-cardiology formula, PCF) was reported to alleviate myocardial ischemia injury and improve depression-like behavior. Interestingly, our previous proteomics study predi...
Main Authors: | Yize Sun, Zheyi Wang, Jiqiu Hou, Jinyu Shi, Zhuoran Tang, Chao Wang, Haibin Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.832590/full |
Similar Items
-
Integrated Analysis Reveals S100a8/a9 Regulates Autophagy and Apoptosis through the MAPK and PI3K-AKT Signaling Pathway in the Early Stage of Myocardial Infarction
by: Weijue Yi, et al.
Published: (2022-06-01) -
Short-Term Blockade of Pro-Inflammatory Alarmin S100A9 Favorably Modulates Left Ventricle Proteome and Related Signaling Pathways Involved in Post-Myocardial Infarction Recovery
by: Raluca Maria Boteanu, et al.
Published: (2022-05-01) -
Positive correlations between plasma BPI level and MPO-DNA and S100A8/A9 in myocardial infarction
by: Shicheng Yu, et al.
Published: (2022-05-01) -
Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction
by: Xueying Zhang, et al.
Published: (2015-01-01) -
S100A8/A9 Enhances Immunomodulatory and Tissue-Repairing Properties of Human Amniotic Mesenchymal Stem Cells in Myocardial Ischemia-Reperfusion Injury
by: Tzu-Jou Chen, et al.
Published: (2021-10-01)